Prognostic value of peritoneal scar-like tissue in patients with peritoneal metastases of ovarian origin presenting for curative-intent cytoreductive surgery
Abstract Background Complete cytoreductive surgery (CRS), remain the gold standard in the treatment of peritoneal metastases of ovarian cancer (PMOC). Given the increasing rate of neoadjuvant chemotherapy in patients with high PCI, prior abdominal surgeries, inflammation and fibrotic changes, the be...
Main Authors: | Antoine El Asmar, Florin Pop, Etienne El Helou, Pieter Demetter, Isabelle Veys, Laura Polastro, Ali Bohlok, Gabriel Liberale |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-023-03153-z |
Similar Items
-
Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
by: Mina Sarofim, et al.
Published: (2024-04-01) -
Prognostic value of preoperative serological biomarkers in patients undergoing cytoreductive surgery for ovarian cancer peritoneal metastases
by: Khaled Charif, et al.
Published: (2023-05-01) -
Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)
by: Israel Manzanedo, et al.
Published: (2023-05-01) -
Cytoreductive surgery for synchronous and metachronous colorectal peritoneal dissemination: Japanese P classification and peritoneal cancer index
by: Akiyoshi Mizumoto, et al.
Published: (2024-01-01) -
Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
by: Waheed Yousry Gareer, et al.
Published: (2022-06-01)